Rituximab 1.4g/11.7ml solution for injection vials
NHS hospitals in England used £14,738,709 of indicative cost of Rituximab 1.4g/11.7ml solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 12.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Rituximab 1.4g/11.7ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Rituximab 1.4g/11.7ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| East Kent Hospitals University Nhs Ft | £466,594 |
| Norfolk & Norwich University Hpl Nhs Trt | £442,390 |
| Univ Hpl B/Ham Nhs Foundation Trust | £415,497 |
| United Lincolnshire Hospitals Nhs Trust | £371,123 |
| South Tees Hosp Nhs Foundation Trust | £360,366 |
| The Christie Nhs Foundation Trust | £344,230 |
| Western Sussex Hospitals Nhs Found Trust | £314,648 |
| North West Anglia Nhs Foundation Trust | £279,687 |
| Royal Cornwall Hospitals Nhs Trust | £271,619 |
| The Clatterbridge Cancer Centre Nhs Ft | £268,930 |
The primary-care picture
Rituximab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Rituximab medicine page.